Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Non-Customized |
Still deciding? Get samples of US$ 100/gram
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
The test results of serum HBV-DNA in most patients with hepatitis B indicate that lamivudine can rapidly inhibit HBV replication, and its inhibitory effect continues throughout the treatment process. At the same time, the serum transaminase can be reduced to normal, and long-term application can significantly improve the inflammatory changes of liver necrosis and reduce or prevent the progress of liver fibrosis.